Body Weight Changes Following Oral and Intravenous Iron Replacement in Women with Iron Deficiency Anemia: A Prospective Cohort Study
SN Comprehensive Clinical Medicine · 31.10.2026 · 8 (1)
DOI: 10.1007/s42399-026-02851-5 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift SN Comprehensive Clinical Medicine, online erschienen am 31.10.2026. Verfasst von Beyza Kal Kolik und 1 weiteren Autor:innen. Die Arbeit nennt 14 Literaturangaben.
Abstract (Originalsprache)
Background
Concerns about weight gain may affect acceptance of and adherence to iron replacement therapy in women with iron deficiency anemia (IDA). Evidence comparing body weight changes following oral and intravenous iron therapy is limited. This study compared three-month body weight changes between oral and intravenous iron therapy and explored accompanying biochemical changes.
Methods
This prospective observational cohort study included 101 women aged 18–50 years with IDA treated between April and August 2023. Fifty received oral iron and 51 received intravenous ferric carboxymaltose. The primary outcome was change in body weight from baseline to three months, with the primary comparison between oral iron and pooled intravenous iron. Multivariable linear regression with HC3 robust standard errors adjusted for age, baseline BMI, hemoglobin, and ferritin. Dose-specific comparisons and biochemical outcomes were secondary; biochemical analyses were exploratory without adjustment for multiple testing.
Results
Body weight increased significantly in all treatment groups (all P < 0.01). In the primary adjusted analysis, pooled intravenous iron was not significantly associated with weight change compared with oral iron (B = − 0.538 kg; 95% CI, − 1.741 to 0.665; P = 0.381). In secondary dose-specific comparisons, median weight gain was 2.0 kg (IQR, 1.0–4.0) with oral iron, 1.2 kg (IQR, 0.0–3.0) with intravenous 1000 mg, and 1.0 kg (IQR, 0.0–3.0) with intravenous 1500 mg (between-group P = 0.041). Hematological and iron parameters improved. Glucose and lipid changes did not differ significantly between groups, while exploratory analyses identified nominal differences in ALT and GGT changes.
Conclusions
Oral and intravenous iron therapy were associated with increased body weight over three months in women with IDA. Treatment route was not significantly associated with weight change after adjustment for baseline characteristics. Exploratory biochemical findings require cautious interpretation.
Zitieren
APA
Kolik, B. K., & Yokuş, O. (2026). Body Weight Changes Following Oral and Intravenous Iron Replacement in Women with Iron Deficiency Anemia: A Prospective Cohort Study. SN Comprehensive Clinical Medicine, 8(1). https://doi.org/10.1007/s42399-026-02851-5
Vancouver
Kolik BK, Yokuş O. Body Weight Changes Following Oral and Intravenous Iron Replacement in Women with Iron Deficiency Anemia: A Prospective Cohort Study. SN Comprehensive Clinical Medicine. 2026;8(1). doi:10.1007/s42399-026-02851-5
BibTeX
@article{Kolik2026,
author = {Kolik, Beyza Kal and Yokuş, Osman},
title = {Body Weight Changes Following Oral and Intravenous Iron Replacement in Women with Iron Deficiency Anemia: A Prospective Cohort Study},
journal = {SN Comprehensive Clinical Medicine},
year = {2026},
volume = {8},
number = {1},
doi = {10.1007/s42399-026-02851-5}
}
EUVIMED